17 February 2016 - Bayer withdrew Xarelto when it failed to get a state subsidy - an unprecedented step for the company in New Zealand. The change poses health risks for patients who have to switch back to other drugs.

For more details, go to: http://www.radionz.co.nz/news/national/296713/patients-left-in-lurch-as-free-drug-pulled?utm_medium=nl&utm_source=internal&mkt_tok=3RkMMJWWfF9wsRokuq%2FOde%2FhmjTEU5z17%2BkqUKG3iokz2EFye%2BLIHETpodcMSMRhNr%2FYDBceEJhqyQJxPr3HJdQN18R7RhHnDg%3D%3D